| SC 13G | 2024-02-14 | Blue Owl Capital Holdings LP | Syros Pharmaceuticals, Inc. | 1,493,252 | 5.7% | EDGAR |
| SC 13G/A | 2024-02-13 | Avidity Partners Management LP | Syros Pharmaceuticals, Inc. | 2,662,206 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-13 | Bain Capital Life Sciences Fund II, L.P. | Syros Pharmaceuticals, Inc. | 2,749,808 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-13 | Ally Bridge MedAlpha Master Fund L.P. | Syros Pharmaceuticals, Inc. | 570,976 | 2.6% | EDGAR |
| SC 13G/A | 2024-02-09 | Artal International S.C.A. | Syros Pharmaceuticals, Inc. | 3,568,842 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-07 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Syros Pharmaceuticals, Inc. | 2,623,984 | 10.0% | EDGAR |
| SC 13G | 2024-01-02 | Point72 Asset Management, L.P. | Syros Pharmaceuticals, Inc. | 1,471,771 | 5.7% | EDGAR |
| SC 13D/A | 2023-12-26 | Samsara BioCapital, L.P. | Syros Pharmaceuticals, Inc. | 2,493,541 | 9.5% | EDGAR |
| SC 13D | 2023-10-20 | Samsara BioCapital, L.P. | Syros Pharmaceuticals, Inc. | 1,588,564 | 7.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Avidity Partners Management LP | Syros Pharmaceuticals, Inc. | 2,144,939 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Bain Capital Life Sciences Fund II, L.P. | Syros Pharmaceuticals, Inc. | 2,124,694 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-13 | Artal International S.C.A. | Syros Pharmaceuticals, Inc. | 1,463,829 | 7.2% | EDGAR |
| SC 13G/A | 2023-01-30 | Ally Bridge MedAlpha Master Fund L.P. | Syros Pharmaceuticals, Inc. | 1,439,379 | 6.9% | EDGAR |
| SC 13G | 2023-01-25 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Syros Pharmaceuticals, Inc. | 1,253,828 | 6.0% | EDGAR |
| SC 13G/A | 2022-11-10 | FMR LLC | Syros Pharmaceuticals, Inc. | 104,614 | 0.5% | EDGAR |
| SC 13G | 2022-09-20 | Avidity Partners Management LP | Syros Pharmaceuticals, Inc. | 2,120,000 | 9.9% | EDGAR |
| SC 13G | 2022-09-19 | Deep Track Capital, LP | Syros Pharmaceuticals, Inc. | 699,281 | 10.0% | EDGAR |
| SC 13D/A | 2022-09-16 | TYME TECHNOLOGIES, INC. | Syros Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13D | 2022-07-13 | Syros Pharmaceuticals, Inc. | TYME TECHNOLOGIES, INC. | 17,819,723 | 9.9% | EDGAR |
| SC 13D | 2022-07-13 | TYME TECHNOLOGIES, INC. | Syros Pharmaceuticals, Inc. | 17,460,552 | 28.0% | EDGAR |